- Home
- SNSE vs SSKN Comparison
SNSE vs SSKN Comparison
Compare SNSE & SSKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNSE
- SSKN
- Stock Information
- Founded
- SNSE 2005
- SSKN 1989
- Country
- SNSE United States
- SSKN United States
- Employees
- SNSE N/A
- SSKN N/A
- Industry
- SNSE Biotechnology: Pharmaceutical Preparations
- SSKN Medical/Dental Instruments
- Sector
- SNSE Health Care
- SSKN Health Care
- Exchange
- SNSE Nasdaq
- SSKN Nasdaq
- Market Cap
- SNSE 10.2M
- SSKN 8.9M
- IPO Year
- SNSE 2021
- SSKN 2005
- Fundamental
- Price
- SNSE $8.81
- SSKN $1.70
- Analyst Decision
- SNSE Strong Buy
- SSKN Strong Buy
- Analyst Count
- SNSE 4
- SSKN 1
- Target Price
- SNSE $72.50
- SSKN $6.00
- AVG Volume (30 Days)
- SNSE 16.6K
- SSKN 2.8M
- Earning Date
- SNSE 08-05-2025
- SSKN 08-13-2025
- Dividend Yield
- SNSE N/A
- SSKN N/A
- EPS Growth
- SNSE N/A
- SSKN N/A
- EPS
- SNSE N/A
- SSKN N/A
- Revenue
- SNSE N/A
- SSKN $32,848,000.00
- Revenue This Year
- SNSE N/A
- SSKN N/A
- Revenue Next Year
- SNSE N/A
- SSKN $9.70
- P/E Ratio
- SNSE N/A
- SSKN N/A
- Revenue Growth
- SNSE N/A
- SSKN 0.36
- 52 Week Low
- SNSE $5.00
- SSKN $1.61
- 52 Week High
- SNSE $17.40
- SSKN $3.86
- Technical
- Relative Strength Index (RSI)
- SNSE 58.00
- SSKN 43.89
- Support Level
- SNSE $7.79
- SSKN $1.61
- Resistance Level
- SNSE $8.69
- SSKN $3.86
- Average True Range (ATR)
- SNSE 0.73
- SSKN 0.36
- MACD
- SNSE 0.08
- SSKN 0.03
- Stochastic Oscillator
- SNSE 79.72
- SSKN 4.00
About SNSE Sensei Biotherapeutics Inc.
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).
About SSKN Strata Skin Sciences Inc.
Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures, which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United States.